Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinic with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs. Learn more about the Iambic team, platform, and pipeline at iambic.ai.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $100M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 25.10.2023 | OrbiMed | orbimed.co... |
| 27.01.2024 | Shanda Gro... | shanda.com |
| - | Catalio Ca... | cataliocap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.10.2023 | Series B | $100M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 06.10.2023 | Iambic Therapeutics Closes $100M Series B Financing | Iambic Therapeutics (formerly known as Entos), a San Diego, CA-based biotechnology company developin... | finsmes.co... |
| 03.10.2023 | Iambic Therapeutics raises $100M in Series B funding to adva... | - | connect.or... |